2019
DOI: 10.1016/j.coi.2019.04.015
|View full text |Cite
|
Sign up to set email alerts
|

The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
123
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 137 publications
(124 citation statements)
references
References 70 publications
1
123
0
Order By: Relevance
“…In the process of activation, the FIIND undergoes self‐cleavage, an event that is required for activation. NLRP1 responds to the enzymatic activities of pathogen effectors such as the lethal toxin (leTox) from Bacillus anthracis and by non‐pathogen‐associated triggers such as the drug Val‐boro‐Pro, an anti‐cancer molecule that inhibits the cytosolic serine proteases Dpp8 and Dpp9 …”
Section: Nlrs Function As Sensors Of Pathogens and Cellular Perturbatmentioning
confidence: 99%
See 1 more Smart Citation
“…In the process of activation, the FIIND undergoes self‐cleavage, an event that is required for activation. NLRP1 responds to the enzymatic activities of pathogen effectors such as the lethal toxin (leTox) from Bacillus anthracis and by non‐pathogen‐associated triggers such as the drug Val‐boro‐Pro, an anti‐cancer molecule that inhibits the cytosolic serine proteases Dpp8 and Dpp9 …”
Section: Nlrs Function As Sensors Of Pathogens and Cellular Perturbatmentioning
confidence: 99%
“…NLRP1 responds to the enzymatic activities of pathogen effectors such as the lethal toxin (leTox) from Bacillus anthracis 21 and by non-pathogen-associated triggers such as the drug Val-boro-Pro, an anti-cancer molecule that inhibits the cytosolic serine proteases Dpp8 and Dpp9. 22,23 Gain-of-function mutations within NLRP1 have been described in humans to cause uncontrolled inflammasome activation promoting a familial autoinflammatory skin disease associated with cancer. 24 Other mutations of NLRP1 have been linked to autoinflammation with arthritis and dyskeratosis (AIADK) also known as NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis).…”
Section: Nlr S Fun C Ti On a S S En Sor S Of Pathog En S And Cellulmentioning
confidence: 99%
“…NLRP1b is a sensor of pathogen effector proteins that induce degradation of its N‐terminus by the proteasome and release of an autoproteolytically‐generated, noncovalently associated C‐terminal CARD domain. The best‐studied activator of this inflammasome, the anthrax lethal factor protease (LF), cleaves the N‐terminus of NLRP1b to initiate destabilization of the protein through ubiquitylation by an N‐end rule E3 ubiquitin ligase 5–8 . Lethal toxin (LT), a major virulence factor of Bacillus anthracis , is an AB toxin comprised of two proteins, the receptor‐binding protective antigen (PA), which binds receptors and transports the second component, LF, to the host cell cytosol, where it cleaves its substrates.…”
Section: Introductionmentioning
confidence: 99%
“…5a). This 'filament-seeding' phenomenon was not limited to the isolated CARDs, as Talabostat-activated full-length NLRP1 and CARD8 also formed filaments 9,15,19 and colocalized with ASC-CARD and CASP-1 CARD filaments, respectively ( Fig. S6).…”
Section: Structural Basis For the Distinct Downstream Card Preferencementioning
confidence: 95%
“…1A) 9,[12][13][14] . NLRP1 and CARD8 both harbor a poorly defined domain known as FIIND, whose auto-proteolytic activity is required for inflammasome activation 15,16 . The requirement of the adaptor protein ASC has also been a matter of debate for CARD-containing sensor proteins such as NLRP1 and NLRC4 17 .…”
Section: Introductionmentioning
confidence: 99%